← Open Payments lookup

SUSAN SCHNITKER: Open Payments

NPI 1508236209 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$805 in 37 payments from 12 companies in 2025. Trend: 2023 $589 · 2024 $1,073 · 2025 $805

Food & beverage: $805
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$297
GlaxoSmithKline, LLC.8$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$78
Novo Nordisk Inc5$76
Novartis Pharmaceuticals Corporation2$42
ABBVIE INC.2$36
Inspire Medical Systems, Inc.1$32
Lilly USA, LLC2$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Exact Sciences Corporation1$18

Products named: AIRSUPRA, TRELEGY ELLIPTA, CAPLYTA, BREZTRI, Wegovy, LEQVIO, FARXIGA, VRAYLAR.

Industry payments across IN — which companies pay providers there.